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Abstract 1 
7KH FU\VWDOOLVDWLRQ Į-para aminobenzoic acid (pABA) from mixed solutions in ethanol (EtOH) and 2 
QLWURPHWKDQH 10H LV UHSRUWHG )URP VROXWLRQV ZLWK FRPSRVLWLRQV !  ZW  10H WKH NQRZQ Į-3 
polymorph of pABA appears. In contrast, crystals prepared from mixed solvent with < 60 wt % NMe 4 
UHYHDOWKHSUHVHQFHRIDSUHYLRXVO\XQNQRZQ10HVROYDWHZKLFKFU\VWDOOLVHVFRQFRPLWDQWO\ZLWKĮ  The 5 
crystal structure of this new form has been determined and is compared with the previously known 6 
VWUXFWXUHRIWKHĮ-polymorph. The crystal structure of the NMe solvate has similar synthonic interactions 7 
ZLWKUHVSHFWWRĮ-p$%$LQSDUWLFXODUWKH2+«2+-ERQGHGGLPHUVDQGWKH1+«2+-bonds between 8 
the pABA molecules. However, the WKHʌ-ʌVWDFNLQJ LQWHUDFWLRQVEHWZHHQ WKHSKHQ\O ULQJJroups are 9 
IRXQGWREHPXFKPRUHRIIVHWDQGGRQRWIRUPDFRQWLQXRXVFKDLQWKURXJKWKHVWUXFWXUHDVIRXQGLQĮ-10 
pABA. The synthonic interactions in the NMe solvate structure are generally weaker than those found in 11 
Į-pABA and the lattice energy is calculated to be significantly lower, suggesting the solvate structure is 12 
PHWDVWDEOHZLWKUHVSHFWWRĮ-p$%$7KHLPSDFW10HRQWKHPRUSKRORJ\RIĮ-pABA crystals, together 13 
with molecular modelling, suggests that this solvent is able to disrupt  WKHʌ-ʌVWDFNLQJLQWHractions that 14 
dominate growth along the needle (b-D[LV GLUHFWLRQ RI Į-pABA. Such interactions are shown to be 15 
intimately linked to the ultimate formation of the solvate. 16 
  17 
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1. Introduction 1 
The demand for active pharmaceutical ingredients (API) to be crystallised with high purity and desirable 2 
physical properties for downstream unit processes, has resulted in increased importance being attributed 3 
to the crystallisation solvent selection process. This is in order to quantify the impact of changes in 4 
solvent composition on the physical characteristics of the crystalline product, such as propensity to form 5 
solvates1-5 and variations in crystal morphology6-13. Since a third of materials are known to produce 6 
solvates14, a detailed understanding of polymorphism and solvate formation can be vital in terms of 7 
consistent production of pure and stable drug products. As a caveat to this, the avoidance of needle-like 8 
morphologies is also important in pharmaceutical and fine chemical product processing, since they can 9 
create problems in downstream processing with their propensity to block filters and pipes, along with 10 
their undesirable mechanical properties that can result in their breakage during filtration15. Therefore, 11 
there is a need to correlate these material properties with molecular and crystal structural packing 12 
features1, 2, 16-18, to design highly pure crystalline particles with pre-defined physical properties. 13 
Solvent screening can be a key step to assess the crystal form and morphology of APIs produced from 14 
solution19, in order to ensure the stability of a drug product and avoid product failure, resulting in the 15 
expensive process of product withdrawal and re-formulation20. Experimental screening can be expensive 16 
and time-consuming, hence computational modelling can be used to guide the solvent selection process 17 
for API crystallisation2, 4, 5, 17, 21-29. Once a stable solid form has been confirmed, the crystallisation of 18 
this form with isotropic crystal morphology can often be desirable. Though the crystallisation of more 19 
isotropic morphologies can sometimes be achieved through control of the solute concentration 20 
(supersaturation) during solution crystallisation30-32, it can also be achieved by manipulating the solvent 21 
composition33-35. Previous studies have demonstrated that an understanding of the individual crystal 22 
surface chemistries, solvent physical properties and solution supersaturation can result in more effective 23 
solvent or additive selection/design for tailoring the crystal growth and morphology36-39. Therefore, the 24 
ability to design crystallisation processes via solvent selection and/or other control techniques is of 25 
significant importance to produce a stable solid form and desirable crystalline physical properties. 26 
Crystallising from a mixture of solvents with different properties can effectively alter the physical 27 
properties (morphology, purity, crystallinity etc.) of a material34, 35, 40. Cook et al41 observed that the 28 
mixture of a strong hydrogen bond (H-bond) donor and a strong H-bond acceptor can cause the deviation 29 
of the solution properties from regular solution theory42. Additionally, Chen et al9 demonstrated the 30 
applicability of using a computational approach to the design of a mixed solvation environment that 31 
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modified the needle-like morphology of 2,6-dihydroxy-benzoic acid. Such studies have identified that 1 
understanding a solution crystallisation environment on the molecular level can aide in rationalising the 2 
solution behaviour and physical properties of the crystals produced.  3 
Drawing upon the above ideas, this study addresses the issue of solvent selection in the crystallisation of 4 
p-amino benzoic acid (pABA), demonstrating firstly how the Cambridge Structural Database (CSD) may 5 
be used as a tool for directing solvent choice, and secondly how state of the art synthonic engineering 6 
tools17, 43, 44 may be used to aid our understanding of how solvents control both the morphology and phase 7 
of resulting solid forms. It is now well known that the ĮDQGȕSRO\PRUSKVRIpABA are enantiotropically 8 
related, having a transition temperature of ~ 14°C45, 46. It has also been reported that only needle-like 9 
crystals of the high temperature stable ĮIRUPDSSHDU from organic solvents (eg alcohols, ethyl acetate, 10 
acetonitrile) regardless of the temperature47, 48. 7KH PRUH SULVPDWLF ȕ pABA only crystallises from 11 
water17, 47, 49, 50. The search for a new solvent was thus initially motivated by the desire to crystallise the 12 
ȕ polymorph directly from an organic solvent. As described below, this search led to the use of 13 
nitromethane (NMe) and nitromethane/ethanol mixtures as the crystallisation media49 and ultimately to 14 
examine the solvent effect on crystalline phase and morphology. The results are rationalised using 15 
molecular modelling of the solvent interaction with both pABA molecules and FU\VWDO VXUIDFHVRIĮ-16 
pABA to attempt to understand, at the molecular level, the observed crystalline structural form and 17 
morphology produced from the different solvent mixtures.   18 
2. Materials and Methods 19 
2.1 Materials 20 
Ethanol was purchased from VWR chemicals having a purity of 99.9% (CAS: 64-17-5). Nitromethane 21 
with > 99% purity was purchased from ACROS Organics (CAS: 75-52-5). The pABA was purchased 22 
from Sigma Aldrich with 99% purity (CAS: 150-13-0). 23 
2.2 Experimental Methods 24 
2.2.1 Solubility Determination 25 
Saturated solutions of Į-pABA in pure EtOH, and EtOH:NMe mixtures (NMe concentration was 26 
increased in 10 wt % steps all the way up to pure NMe)  were prepared at the 10ml scale, agitated at the 27 
desired temperature for 24 hours and allowed to settle for 12 hours, when the supernatant was pipetted 28 
into a fresh sample vial and dried. The mass of solid was weighed using a 4-figure balance and the mass 29 
checked over 3 days to ensure all solvent had evaporated. 30 
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2.2.2 YDQ¶W Hoff Solubility Analysis  1 
If a solution is assumed to be ideal, that is the solute/solute, solute/solvent and solvent/solvent 2 
interactions are all equal, then the ideal solid/liquid equilibrium can be expressed, assuming a negligible 3 
contribution from the heat capacity, as Equation (1)  4 ሺݔሻ ൌ οு೑ೠೞோ ቂଵ் െ ଵ்೘ቃ (1) 5 
where ܴ is the ideal gas constant, οܪ௙௨௦ is the enthalpy of fusion, ܶ is the temperature and ௠ܶ is the 6 
melting temperature of Į-pABA51. However, since most solutions are non-ideal, the YDQ¶W Hoff equation 7 
can be used to assess the degree of non-ideality, shown in Equation (2) 8 ሺݔሻ ൌ െ οு೏೔ೞೞோ் ൅ οௌ೏೔ೞೞோ  (2) 9 
where οܪௗ௜௦௦ and οܵௗ௜௦௦ are the enthalpy and entropy of dissolution, respectively. Since ܴ, ܶ, οܪௗ௜௦௦ 10 
and οܵௗ௜௦௦  are constants, the solubility can be plotted as ሺݔሻ vs ଵ். Solubility SORWWHG LQ YDQ¶W +RII11 
coordinates that is found to be above the ideal line implies that the solute/solvent interactions are stronger 12 
than the solvent/solvent interactions. Conversely, if the solubility is found to be below the ideal line, this 13 
then implies that the solvent/solvent interactions are stronger than the solute/solvent interactions. A more 14 
in-depth derivation and analysis of this theory can be found in a previous publication52. 15 
2.2.3 Crystallisation Screening 16 
The crystals were obtained from cooling crystallisation in EtOH:NMe solvent mixtures of 0% (by 17 
weight) to 100% NMe content, at two supersaturations of S = 1.1 and S = 1.3. 10 g of solvent with the 18 
appropriate amount Į-pABA were agitated at 50ºC using a Julabo53 F25 circulator for an hour to ensure 19 
full dissolution of the solid. Then the agitation was halted and the solutions cooled to 10ºC and left to 20 
crystallise, whereby crystallisation occurred within 5 days. Solutions were vacuum filtered to isolate the 21 
solid crystalline form from the solution. 22 
Crystals of the pure nitromethane solvate were prepared using slow solvent evaporation. 5 ml of pure 23 
nitromethane was saturated with Į-pABA at ambient temperature and pressure, this was then filtered into 24 
a clean 10 ml screw cap vial and covered using plastic paraffin film with a single hole punctured through 25 
using a clean needle. The solvent was allowed to evaporate slowly over 3 days; the resulting crystals 26 
were isolated using vacuum filtration and air dried.  27 
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2.2.4 Crystal Morphology Characterisation 1 
The crystals obtained were imaged by high quality photography using an Olympus Style TG4 camera.  2 
2.2.5 Structural Characterisation 3 
Powder X-ray diffraction (PXRD) of the samples was carried out using a Bruker D8 advanced X-ray 4 
diffractometer, ZKLFK XVHG &X .Į UDGLDWLRQ DQG D JHUPDQLXP SULPDU\ PRQRFKURPDWRU LQ a Bragg-5 
%UHQWDQRUHIOHFWLRQJHRPHWU\7KHVWHSVL]HXVHGZDVș, ZLWKDVWHSWLPHRIVVWHSRYHUDș6 
range of 5 - 39.8° ș 7KH GHWHFWRU XVHG ZDV a Vantec-1 position sensitive detector. Samples were 7 
prepared by grinding crystallisation products in a mortar and pestle and mounting on a flat plate sample 8 
holder. Data reduction and Rietveld analysis were performed using PANalytical Highscore plus 9 
software54. 10 
For single X-ray diffraction, crystals were immersed in inert oil and mounted on a nylon loop. These 11 
were then cooled to 100 K using an Oxford Cryosystems 700 Series Crysostream Cooler55 and data 12 
collected on a RigakuSuperNova diffractometer fitted with an Atlas CCD detector with monochromated 13 
Mo-.ĮUDGLDWLRQȜ c7KHdataset was collected and processed using CrysAlisPRO56 and 14 
corrected for absorption using an analytical numeric correction57; the structure solved using SHELXS58 15 
and refined by full-matrix least squares on F2 using ShelXL-201459 interfaced through the programme 16 
Olex260. Molecular graphics and tables of data were produced using Olex260. All non-hydrogen atoms 17 
were located in the Fourier Map and refined anisotropically. All hydrogen atoms bound to carbon were 18 
placed in calculated pRVLWLRQVDQGUHILQHGLVRWURSLFDOO\XVLQJD³ULGLQJPRGHO´ 19 
2.3 Computational Methods  20 
2.3.1 Overlaying of Molecular Structures 21 
The molecular structures were overlaid using the 3-point fit module with Interchem 201361, 62.  22 
2.3.2 Synthon Characterisation  23 
The strength and nature of the intermolecular interactions in the bulk crystal structure (intrinsic synthons) 24 
were characterised using HABIT9863. A nest of unit cells was constructed in three dimensions, and the 25 
interactions between a molecule in the central unit cell and all of the other molecules in the surrounding 26 
unit cells was calculated. The atom-atom parameters published by Momany et al64 together with 27 
fractional charges calculated using the AM1 method within MOPAC65, 66 were used to calculate the 28 
strength of the intermolecular interactions in this study. This method for calculating synthon strength has 29 
been widely used in the molecular modelling of organic materials17, 65, 67-70. 30 
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2.3.3 Molecular and Surface Grid-Based Searching 1 
The most favoured binding sites between the solute and solvents were identified using the systematic 2 
search program71-73. The program operates with a stationary and mobile phase, in this case they can be 3 
VLQJOHPROHFXOHVRUGLPHUVVRZLOOVLPSO\EHUHIHUUHGWRDVDµERG\¶7KHVWDWLRQDU\ERG\LVIL[HGZKLOst 4 
the mobile body moves around the stationary body on a grid. At each grid point, the mobile phase can 5 
also rotate about three angles. At each point and rotation, the intermolecular energy was calculated using 6 
the same potential parameters mentioned in Section 2.3.2. 7 
In this study, the most favoured binding sites of up to 5 molecules of NMe and ethanol with a pABA 8 
dimer were identified. The binding sites were searched sequentially. For the first simulation, the pABA 9 
dimer was held rigid and the solvent molecule was moved around the grid surrounding the dimer and the 10 
most favourable interaction between a solvent molecule and the dimer was identified. The coordinates 11 
for the most favoured interaction between the pABA dimer and one solvent molecule was used as the 12 
starting point for the second simulation, where it was held rigid and a second solvent molecule was 13 
searched in the same way as the first simulation to find the most favoured binding site of a second solvent 14 
molecule. This search procedure was repeated for up to 5 molecules of the solvent. 15 
For the surface searching74, 75, a crystal surface, represented by a slab, was generated and the slab was 16 
then treated as a fixed body during searching process. The thickness of the slab was selected to be a 17 
multiple of the d-spacing (dhkl) between adjacent (hkl) lattice planes, whilst the surface area was a 18 
multiple of the crystal unit cell sizes. Therefore, the surface is embedded in an n1 u n2 u n3 matrix to 19 
eliminate the edge effects on the search results. The grid cells were generated based on three orientations 20 
of the mobile body and two spherical polar angles between the two bodies, but only covering half of the 21 
space facing the crystal surface, i.e., the azimuthal angle from 0 to 180o. The search explored every grid 22 
point and calculated the interaction energy between the slab and the mobile body (a probe molecule or 23 
cluster), and hence identify the most favourable sites for the mobile body to dock on or interact with the 24 
slab surface. 25 
 26 
 27 
 28 
 29 
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3. Results and Discussion 1 
3.1 Solvent Selection Application of the Cambridge Structural Database  2 
A starting point in this study was a search of the CSD, with the objective of identifying molecular 3 
functionalities that could preferentially interact with the acid group of pABA. Accordingly the CSD was 4 
searched for all crystal structures containing the pABA moiety. Excluding the 6 entries for pure pABA 5 
and the structures in which pABA adopted the acid dimer, this amounted to 42 hits in which the acid 6 
hydroxyl was bound to a non pABA group. Of these, 29 involved H-bonds directly to a nitrogen (as 7 
pyridine, bipyridine, imidazole) and 13 were bound to oxygen either as carbonyl (6), water (2) or nitro 8 
(5) functionality. On this basis, it was surmised that nitromethane would be an interesting solvent to 9 
explore since it had not previously been chosen for crystallisation experiments. To our knowledge this is 10 
the first report of the application of the CSD in solvent selection.  11 
3.2 Solubility 12 
Figure 1 shows the solubility measured in pure EtOH, NMe, and in mixtures of EtOH/ NMe in steps of 13 
10% by weight in the temperature range 10 - 30°C. 14 
 15 
 16 
 11 
 
 1 
 2 
Figure 1: The solubility for the different solvent compositions plotted using the YDQ¶W Hoff 3 
relationship with the ideal solubility (equation 1) indicated by the solid black line;  4 
 5 
The data in Figure 1(b) shows that only the solubility up to about 30% NMe content was above the ideal 6 
solubility line, consistent with the increase in solubility seen upon addition of small amounts of NMe 7 
(Figure S1(a), supplementary material). It was also observed that the solubility at lower temperatures 8 
was further above the ideal solubility than at higher temperatures, which suggests that these liquids may 9 
be able to be significantly undercooled and remain stable52. 7KHODUJHHUURUVREVHUYHGIRUWKHYDQ¶W+RII10 
coordinates for pure NMe were due to the small amount of material produced from the solubility 11 
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experiments, hence when measuring the mass of the material, any small deviation in the mass was 1 
translated into a large percentage error. 2 
 3 
3.3 Crystallisation from EtOH:NMe Mixtures 4 
Cooling crystallisation experiments yielded crystalline particles from all the solutions except pure 5 
nitromethane, where after 5 days no crystalline material could be obtained. The comparison of the PXRD 6 
spectra of the crystals produced at 10oC from the solutions containing 10%, 30%, 50% and 80% NMe 7 
are shown in Figure 2. 8 
 9 
 10 
Figure 2: Comparison of the PXRD spectra of the crystals produced from the solution containing 11 
10% NMe (red); 30% NMe (green); 50% NMe (blue) and 80%NMe (black). New peaks labelled 12 
DUHSHDNVQRWFRQVLVWHQWZLWKĮ-pABA structure 13 
 14 
The crystals produced from the 90:10 EtOH:NMe sample displayed peaks that were consistent with the 15 
Į-pABA pattern, along with some prominent peaks not present in WKHĮ-pABA pattern ODEHOOHGµQHZ16 
diffraction SHDNV¶ in Figure 2). These previously unseen peaks, consistent with the crystallisation of a 17 
 13 
 
mixture of phases, were also observed in the 30:70 and 50:50 diffraction patterns, albeit at much lower 1 
intensities than in the 90:10 pattern. However, the 20:80 pattern showed no evidence of these previously 2 
unseen peaks.   3 
A single crystal formed from cooling crystallisation of a highly supersaturated solution of pure NMe was 4 
isolated and subject to single crystal XRD. This revealed (see section 3.4) that a pABA:NMe solvate 5 
structure had been formed. The calculated PXRD pattern based on this solvate was consistent with, and 6 
hence explained, the previously unseen peaks found in some of the PXRD patterns from the mixed 7 
solutions were due to concomitant crystallisation of the NMe solvate and Į-pABA phases (Figure 2). 8 
Figure 3 shows the comparison of calculated PXRD patterns of the NMe solvate and Į-pABA structures, 9 
with the PXRD patterns from the crystals produced from solutions containing 10%, 20%, 30% and 50% 10 
NMe content. 11 
 12 
Figure 3: Overlay of experimental diffraction patterns for the 10, 20, 30 and 50% NMe samples, 13 
which contained peaks related to the solvate phase, with a comparison to the simulated diffraction 14 
patterns of the NMe solvate and Į-pABA structure files  15 
 16 
 14 
 
Figure 3 VKRZVWKDWWKHµQHZSHDNV¶IURPFigure 2 can be attributed to the 010, 01-2 and 01-3 peaks of 1 
the solvate crystal structure. The quantity of the solvate in each sample was calculated by full pattern 2 
Rietveld analysis, ZLWKSDWWHUQILWWLQJWRERWKWKHĮ-pABA and the solvate structure files.  3 
Table 1: Weight percentage values of the solvate in the samples containing solvate peaks, together 4 
with the goodness of fit of the Rietveld refinement. *Solution did not crystallise over 5 days using 5 
the method described in section 2.2.3, hence the production of the pure NMe solid was achieved 6 
using slow solvent evaporation in pure NMe 7 
 8 
Table 1 shows that in general, the amount of solvate present in the samples is reduced with increasing 9 
NMe content, with a maximum 80.1% of the solvate in the 10% NMe sample. It was observed that the 10 
samples with 40% and 70-90% NMe content contained no evidence of the solvate structure. It was also 11 
observed that the time taken to crystallise the solid increased with increasing NMe content in the solution. 12 
Therefore this suggests that the decrease in the amount of solvate structure with increasing NMe content 13 
could be consistent with a meta-stablity of the solvate structure, i.e. with increased induction time to 14 
FU\VWDOOLVDWLRQUHVXOWLQJLQWKHPRUHVWDEOHĮ-pABA structure. If the solvate phase was the more stable 15 
phase, it would be expected that the increase of NMe content would enhance the crystallisation of the 16 
solvate phase, however the fact that the solvent composition would impact on the transition temperature 17 
between the two phases must also be considered. From the data collected it seems likely that the Į-phase 18 
is more stable than the solvate phase, and that nitromethane impacts on the relative crystallisation rates 19 
of the two forms.   20 
However, it should be highlighted that the 100% NMe sample included in Table 1 was produced from a 21 
slow solvent evaporation experiment in pure NMe, which yielded a solid of the pure NMe solvate and a 22 
separate solid which was a mixture of Į-pABA and the NMe solvate. This therefore suggests that it takes 23 
extremely careful control over the crystallisation conditions to produce a sample of the pure NMe solvate 24 
structure.  25 
It should also be mentioned that for the solubility measurements given in Figure 1, the solid phase that 26 
was harvested from the supernatant was assumed to be Į-pABA. However, considering that it has now 27 
Sample 100% NMe* 
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50% 
NMe 
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 15 
 
been shown in Figures 2 and 3, along with Table 1, that a mixture of the Į-pABA and NMe solvate 1 
phases can be obtained from the cooling crystallisation experiments in the EtOH:NMe solvent mixtures. 2 
Therefore, it must be stated that the solubility measurements quoted here could be influenced by the 3 
conversion of any of the material to the NMe solvate, and that the solubility of this form is currently 4 
unknown. Hence, a future study that further examines the crystalline phase obtained from the gravimetric 5 
analysis solubility measurements, along with identifying the solubility of the solvate phase, could be of 6 
interest. 7 
3.4 Solvate Crystal Structure and Chemistry 8 
The unit cell and packing of the solvate crystal structure is shown in Figure 4. 9 
 10 
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Figure 4: (a) asymmetric unit of occupancy 1 (54%); (b) asymmetric unit of occupancy 2 (46%);  12 
(c) packing of the NMe solvate structure in the yz plane, black line identifying the tetramer 13 
FRPPRQWRWKHĮ-pABA structure and solvate structure; (d) pDFNLQJRIWKHĮ-pABA structure in 14 
WKH[]SODQHEODFN OLQH LGHQWLI\LQJ WKH WHWUDPHUFRPPRQ WR WKHĮ-pABA structure and solvate 15 
structure.  16 
 17 
Figure 4(a) shows that the solvent molecule with 54% occupancy was found to have both oxygens less 18 
than 3 Å away from H11A on the amino group of pABA, whilst the NMe molecule was found to be 19 
rotated in the 46% occupancy with O23B being found to be 4.8 Å away from H11A 20 
It was observed in the PXRD patterns of the crystals produced from the different solvent mixtures that 21 
some peaks were found to shift non-V\VWHPDWLFDOO\LQșIURPVDPSOHWRVDPSOH7KLVwas attributed to 22 
the disorder of the NMe in the structure, whereby the NMe could occupy the different atomic positions 23 
identified from the single crystal structure, or even a mixture of the two (full details in supplementary 24 
material). 25 
The black lines in Figure 4 (c) and (d) highlight the existence of essentially identical H-bonded tetramers, 26 
(two acid dimers linked E\DQ1+«2K\GURJHQbond), which exist in both the solvate and Į-pABA 27 
structure. This would suggest that, analogous to the Į-VWUXFWXUHWKDWWKH2+«2+-bonding dimers play 28 
(c) 
(d) 
 17 
 
a significant role in stabilising the crystal structure of the solvate. The orientations of the two carboxylic 1 
acid H-bonding dimers within the two crystal structures are compared in Figure 5. 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
Figure 5(a) shows how the two independent acid dimers pack with the ring structures approximately 17 
pointing in the same direction, allowing for efficient close stacking of the dimers through their ring 18 
structures along the b-axis17, 49. Comparing (c) and (d), it was found that the stacking of the pABA dimers 19 
LQ WKHVROYDWHVWUXFWXUHGZHUHIDUPRUHRIIVHWIURPHDFKRWKHUWKDQLQWKHSXUHĮ-pABA structure 20 
((c)), and the measured distance between two adjacent carbonyl carbons was found to be approximately 21 
1 Å greater in the solvate structure. ,WFDQDOVREHREVHUYHGWKDWWKHVWDFNLQJLQWHUDFWLRQVLQWKHĮ-structure 22 
form in a continuous and unbroken chain, approximately in the direction of the b-axis. In comparison, 23 
the stacking in the NMe solvate structure was found to be isolated interactions, UDWKHUWKDQDFKDLQRIʌ-24 
ʌVWDFNLQJ 25 
(c) 
(d) 
(a) 
(b) 
Dimers can stack approximately 
along the b-axis direction in Į-
structure 
Dimers are twisted and 
cannot stack in the same 
direction in solvate 
structure 
Figure 5: (a) the orientation of the two independent carboxylic H-ERQGLQJGLPHUVZLWKLQ WKHĮ-
pABA structure; (b) Orientation of the two independent carboxylic acid H-bonding dimers and the 
NMe molecule within the NMe solvate structure; (c) the stacking of the carboxylic acid dimers in 
Į-pABA; (d) stacking of the carboxylic acid pABA dimers in the NMe solvate structure 
 18 
 
The b-D[LVRIWKHVROYDWHVWUXFWXUHZDVIRXQGWROHQJWKHQLQFRPSDULVRQWRWKHĮ-pABA structure. Figure 1 
4(d) shows that the NMe molecule is situated between the rings of two pABA molecules, hence forcing 2 
the extension along the b-D[LV,QWKHĮ-pABA structure, both dimers are approximately in the same plane 3 
(Figure 5(a)) and the hydrogen bonds are directed approximately in the A and C directions, hence they 4 
are approximately the same in length. In the solvate structure, the twisting of the dimers to accommodate 5 
the NMe molecule has resulted in the dimers no longer being in the same plane running along the a-axis, 6 
hence the a-axis has reduced (Figure 4(c) and (d)). 7 
The calculated strength of the intermolecular interactions (synthons) found within the NMe solvate is 8 
shown in Table 2, along with visualisation of the pairwise interactions. 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 19 
 
Table 2: Strongest synthons calculated from the bulk structure of the NMe solvate structure and 1 
FRPSDUHGWRWKHVWURQJHVWV\QWKRQVIURPWKHĮ-pABA structure. Synthons visualised either side of 2 
the table for each structure 3 
 4 
  5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
Lattice Energy (kcal/mol) 
Nme Solvate Į-pABA 
-17.59 -24.45 
Synthon strengths 
(kcal/mol) 
A solv: -4.35 $Į-5.67 
B solv: -2.09 %Į-2.68 
C solv: -2.07 &Į-2.27 
D solv: -1.77 'Į-1.21 
E solv: -1.63 (Į-0.95 
F solv: -1.53 )Į-1.13 
 20 
 
The lattice energy calculated for the solvate structure was found to be almost 7 kcal/mol less than the 1 
ODWWLFHHQHUJ\FDOFXODWHGIRUĮ-pABA. Synthons A, B and C were found to be structurally similar to the 2 
VWURQJHVWV\QWKRQVIRXQG LQDVWXG\RI WKHĮ-pABA crystal structure17, however they were in general 3 
FDOFXODWHGWREHZHDNHULQWKH10HVROYDWHVWUXFWXUHZKHQFRPSDUHGWRWKHLUFRXQWHUSDUWVLQWKHĮ-pABA 4 
structure17. The significantly reduced calculated lattice energy, weaker synthons and decrease in packing 5 
density (Table S2) is consistent with a metastable structure, which correlates to the crystallisation data 6 
in Section 3.3 6RPH H[WUD K\GURJHQ ERQGLQJ LQWHUDFWLRQV ZHUH DOVR LGHQWLILHG DQ 1+«2 +-bond 7 
between the p$%$DQG10HPROHFXOHVDQGDQ1+«1+-bond between the pABA molecules, which 8 
was not found to be preseQW LQ WKH Į-pABA structure17. The presence of the extra hydrogen bonds 9 
probably somewhat compensates for the general weaker intermolecular synthonic structure, hence 10 
stabilising the crystal structure. 11 
3.5 Crystal Morphologies from Mixed Solvents 12 
Figure 6 shows images of the crystals produced from the cooling crystallisation experiments. 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
Figure 6: Images of pABA crystallised at S = 1.1 at 10°C from pure EtOH up to 90:10 NMe:EtOH 26 
ratio   27 
 28 
Figure 6 shows that the crystals produced from solutions with increasing NMe content were found to 29 
decrease in aspect ratio and become more opaque.  Table 1 indicated that the crystals produced from 30 
100% EtOH 90%:10% 80%:20% 
EtOH:NMe 
70%:30% 60%:40% 
EtOH:NMe 
50%:50%  
40%:60% 30%:70% 20%:80% 
EtOH:NMe 
10%:90% 
 21 
 
solutions with above 60% NMe content were pure Į-pABA, therefore suggesting that the increasing NMe 1 
content reduces the aspect ratio of pure Į-pABA crystals. Figure 6 also showed that the crystals became 2 
more facetted and have smoother surfaces with increasing NMe content. Previous studies suggested that 3 
the capping faces which terminate the b-axis of Į-pABA grow by a rough interfacial growth mechanism 4 
from ethanol76 and that they are often not well formed upon solution crystallisation49. Therefore, addition 5 
of NMe to the solutions appears to stabilise the interface and encourage slower, stable growth of the Į-6 
pABA capping faces.  7 
3.6  Rationalisation of the Morphological and Structural Data through 8 
Solute/Solvent Interaction Modelling 9 
The acid GLPHULVSUHVHQWLQERWKWKHĮ-pABA structure and the solvate structure; therefore the binding 10 
of NMe and EtOH was compared using the systematic search shown in Figure 7.  11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
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 6 
 7 
 8 
 9 
(c) 
(a) 
(b) 
Figure 7: (a) Comparison of the sequential systematic searching of 6 molecules of ethanol (left) and 
nitromethane (right); (b) energetic contributions to the sequential molecular binding calculated by 
the systematic search for ethanol (left) and nitromethane (right) (c) most favoured orientation for 
a probe molecule of ethanol (left) and nitromethane (right) at the (0 1 -VXUIDFHRIWKHĮ-form of 
pABA.   
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Figure 7 (a) shows that the EtOH molecules were found to prefer to bind to the COOH and NH2 groups, 1 
whilst the NMe molecules were found to prefer to bind to the NH2 group and the phenyl ring. This 2 
correlates to the orientation of the NMe molecule found within the solvate structure (Figure 4). This 3 
observation may be related to the maximum observed in the solubility dependence of pABA on NMe 4 
content. This would imply that at a level of 10% NMe in EtOH both the phenyl ring and the carboxylic 5 
acid group of pABA experience their maximum solvation.  6 
Figure 7 (b) revealed that the vdW interactions had a relatively small contribution to the binding energy 7 
for the EtOH molecule. However, after the addition of a fifth NMe molecule, the vdW contribution to 8 
the energy started to increase strongly, consistent with the NMe molecule having a stronger interaction 9 
with the phenyl ring. This is supported by Figure 7(c), which shows that the systematic search suggested 10 
that, in its most favourable position, the NMe molecule prefers to lie across the phenyl ring at the capping 11 
IDFHRIĮ-pABA, whilst EtOH adopts a more orthogonal orientation in order to bind most strongly to the 12 
COOH group.   13 
It is interesting to comment that, as well as nitromethane, solvate structures have been produced from 14 
acetone and dioxane77. In contrast, though there have been extensive studies of the crystallisation of 15 
pABA from polar protic solvents, such as water and ethanol, no solvate structures have been found and 16 
Į-pABA often crystallises45-47, 52, 78. This observation could correlate with the fact that EtOH, which is a 17 
polar and protic solvent, was found to prefer to strongly interact with the COOH group of pABA. The 18 
COOH group forms several strong interactions with other pABA molecules in the Į-pABA structure, 19 
implying that there is probably not much space around this group. In contrast, the NH2 and phenyl ring 20 
groups probably have a greater amount of space around them in the structure, and the NMe molecule is 21 
found to have a greater propensity to interact with those groups. Indeed, the NMe molecule is found to 22 
be interacting primarily with the NH2 group in the solvate structure. Hence, this implies that the space 23 
around functional groups, along with the solvent/solute interactions with respect to these functional 24 
groups, has a strong influence on the propensity of a particular solvent to produce a solvated crystalline 25 
form.  26 
We also suggest that the solute/solvent interactions in the crystal structure and calculated from the 27 
molecular and surface systematic searches have implications with respect to the changes in crystal 28 
morphology observed in Section 3.5. ,WKDVEHHQREVHUYHGWKDWDWWKHFDSSLQJVXUIDFHRIĮ-pABA, the 29 
pABA molecules integrate into the suUIDFHE\IRUPLQJʌ-ʌVWDFNLQJLQWHUDFWLRQVEHWZHHQWKHSKHQ\OULQJ30 
structures17. Therefore the observation that the NMe molecule has a greater propensity to interact with 31 
 24 
 
the phenyl ring, in comparison with ethanol, could imply that the presence of NMe results in the observed 1 
reduction of the aspect ratio of crystals produced from solutions of increasing NMe concentration. The 2 
surface search results shown in Figure 7(c) suggest that, at the capping face, the binding of the NMe 3 
FRXOGSRWHQWLDOO\KLQGHUWKHIRUPDWLRQRIWKHFKDLQRIʌ-ʌVWDFNLQJLQWHUDFWLRQVWKDWDUHWKRXJKWWRVWURQJO\4 
influence the needle-OLNHPRUSKRORJ\RIĮ-pABA16-18, 49. This is supported by the observation that such 5 
chains of close stacking phenyl rings in the p$%$PROHFXOHVREVHUYHGLQWKHĮ-pABA structure, were 6 
found to be absent in the solvate.  7 
 8 
4. Conclusions 9 
This study has demonstrated for the first time how a combined use of the CSD, crystal structure analysis 10 
and molecular and crystal surface modelling of the solute-solvent interactions, can provide an insight 11 
into the crystalline form and morphology produced from the different solvent mixtures. The calculated 12 
propensity of NMe to interact more strongly with the NH2 and phenyl ring groups, in comparison to a 13 
polar protic solvent like EtOH which was calculated to prefer to interact with the COOH group, probably 14 
resulted in the formation of the solvate structure, as there was space around the NH2 group for  the NMe 15 
molecule to be accommodated.  16 
The observed disorder of the NMe molecules in the solvate crystal structure accounted for the shifting 17 
of the peaks in the PXRD, suggesting that the solvate structure could occupy different occupancies when 18 
crystallised from solution. This correlated well to the calculated weaker synthonic interactions in the 19 
VROYDWHVWUXFWXUHLQFRPSDULVRQWRWKHĮ-VWUXFWXUHDORQJZLWKWKHREVHUYDWLRQWKDWĮ-pABA dominated 20 
the crystallisation from solutions with >60% NMe content, due to the increased crystallisation time. 21 
The greater propensity of the NMe molecule to interact strongly with the phenyl ring group of pABA, 22 
DORQJZLWK WKHREVHUYHGGLVUXSWLRQ LQ WKHʌ-ʌ VWDFNLQJ LQWHUDFWLRQV LQ WKH VROYDWH VWUXFWXUH KDV EHHQ23 
correlated to the decrease in aspect ratio of crystals produced from solutions with increasing NMe content. 24 
6LQFHWKHʌ-ʌVWDFNLQJLQWHUDFWLRQVGRPLQDWHWKHJURZWKDORQJWKHORQJD[LVRIWKHQHHGOHWKHSUHVHQFH25 
of NMe indicates its disruption to these interactions, hence slowing down the growth along the long axis 26 
of the needle, producing the observed isotropic morphologies. 27 
This work demonstrates how molecular and crystallographic modelling tools can be combined with in-28 
depth particle analysis to explain the changes in physical properties of a crystalline material. This work 29 
can assist in the on-going efforts to improve the digital design of crystallisation from solution, in relation 30 
 25 
 
to assisting the cleaner and more efficient manufacture of pharmaceutical and fine chemical particulate 1 
products. 2 
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